BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12017272)

  • 1. A promoter region of midkine gene can activate transcription of an exogenous suicide gene in human pancreatic cancer.
    Yoshida Y; Tomizawa M; Bahar R; Miyauchi M; Yamaguchi T; Saisho H; Kadomatsu K; Muramatsu T; Matsubara S; Sakiyama S; Tagawa M
    Anticancer Res; 2002; 22(1A):117-20. PubMed ID: 12017272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell growth- and P53-dependent transcriptional activity of the midkine promoter confers suicide gene expression in tumor cells.
    Yu L; Ugai S; O-Wang J; Namba M; Kadomatsu K; Muramatsu T; Matsubara S; Sakiyama S; Tagawa M
    Oncol Rep; 2003; 10(5):1301-5. PubMed ID: 12883697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A minimum c-erbB-2 promoter-mediated expression of herpes simplex virus thymidine kinase gene confers selective cytotoxicity of human breast cancer cells to ganciclovir.
    Maeda T; O-Wang J; Matsubara H; Asano T; Ochiai T; Sakiyama S; Tagawa M
    Cancer Gene Ther; 2001 Nov; 8(11):890-6. PubMed ID: 11773979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Midkine promoter-based adenoviral vector gene delivery for pediatric solid tumors.
    Adachi Y; Reynolds PN; Yamamoto M; Grizzle WE; Overturf K; Matsubara S; Muramatsu T; Curiel DT
    Cancer Res; 2000 Aug; 60(16):4305-10. PubMed ID: 10969765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of herpes simplex virus-thymidine kinase gene controlled by a promoter region of the midkine gene confers selective cytotoxicity to ganciclovir in human carcinoma cells.
    Miyauchi M; Yoshida Y; Tada Y; Narita M; Maeda T; Bahar R; Kadomatsu K; Muramatsu T; Matsubara S; Nakagawara A; Sakiyama S; Tagawa M
    Int J Cancer; 2001 Mar; 91(5):723-7. PubMed ID: 11267987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A promoter region of the midkine gene that is frequently expressed in human hepatocellular carcinoma can activate a suicide gene as effectively as the alpha-fetoprotein promoter.
    Tomizawa M; Yu L; Wada A; Tamaoki T; Kadomatsu K; Muramatsu T; Matsubara S; Watanabe K; Ebara M; Saisho H; Sakiyama S; Tagawa M
    Br J Cancer; 2003 Sep; 89(6):1086-90. PubMed ID: 12966430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Midkine promoter can mediate transcriptional activation of a fused suicide gene in a broader range of human breast cancer compared with c-erbB-2 promoter.
    Yu L; Yamamoto N; Kadomatsu K; Muramatsu T; Matsubara S; Sakiyama S; Tagawa M
    Oncology; 2004; 66(2):143-9. PubMed ID: 15138367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional regulatory regions of the survivin gene activate an exogenous suicide gene in human tumors and enhance the sensitivity to a prodrug.
    Kawamura K; Yu L; Tomizawa M; Shimozato O; Ma G; Li Q; Sato A; Yang Y; Suzuki T; Abdel-Aziz NM; Tagawa M
    Anticancer Res; 2007; 27(1A):89-93. PubMed ID: 17352220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Midkine and cyclooxygenase-2 promoters are promising for adenoviral vector gene delivery of pancreatic carcinoma.
    Wesseling JG; Yamamoto M; Adachi Y; Bosma PJ; van Wijland M; Blackwell JL; Li H; Reynolds PN; Dmitriev I; Vickers SM; Huibregtse K; Curiel DT
    Cancer Gene Ther; 2001 Dec; 8(12):990-6. PubMed ID: 11781662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional activation of the thyroglobulin promoter directing suicide gene expression by thyroid transcription factor-1 in thyroid cancer cells.
    Shimura H; Suzuki H; Miyazaki A; Furuya F; Ohta K; Haraguchi K; Endo T; Onaya T
    Cancer Res; 2001 May; 61(9):3640-6. PubMed ID: 11325833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyadenylation signal facilitates the expression of foreign gene that is driven by an internal promoter located in the reverse orientation to long terminal repeat of retrovirus.
    Narita M; Takanaga K; Yoshida Y; Kadomatsu K; Muramatsu T; Matsubara S; Hamada H; Goto S; Saisho H; Sakiyama S; Tagawa M
    Anticancer Res; 2000; 20(1A):279-82. PubMed ID: 10769667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies to accomplish targeted expression of transgenes in ovarian cancer for molecular therapeutic applications.
    Casado E; Gomez-Navarro J; Yamamoto M; Adachi Y; Coolidge CJ; Arafat WO; Barker SD; Wang MH; Mahasreshti PJ; Hemminki A; Gonzalez-Baron M; Barnes MN; Pustilnik TB; Siegal GP; Alvarez RD; Curiel DT
    Clin Cancer Res; 2001 Aug; 7(8):2496-504. PubMed ID: 11489832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combinatory gene therapy with electrotransfer of midkine promoter-HSV-TK and interleukin-21.
    Hanari N; Matsubara H; Hoshino I; Akutsu Y; Nishimori T; Murakami K; Sakata H; Miyazawa Y; Ochiai T
    Anticancer Res; 2007; 27(4B):2305-10. PubMed ID: 17695518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional targeting of virus-mediated gene transfer by the human hexokinase II promoter.
    Määttä AM; Korja S; Venhoranta H; Hakkarainen T; Pirinen E; Heikkinen S; Pellinen R; Mäkinen K; Wahlfors J
    Int J Mol Med; 2006 Nov; 18(5):901-8. PubMed ID: 17016620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined suicide gene therapy for pancreatic peritoneal carcinomatosis using BGTC liposomes.
    Hajri A; Wack S; Lehn P; Vigneron JP; Lehn JM; Marescaux J; Aprahamian M
    Cancer Gene Ther; 2004 Jan; 11(1):16-27. PubMed ID: 14681723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Midkine promoter-driven suicide gene expression and -mediated adenovirus replication produced cytotoxic effects to immortalised and tumour cells.
    Yu L; Hamada K; Namba M; Kadomatsu K; Muramatsu T; Matsubara S; Tagawa M
    Eur J Cancer; 2004 Jul; 40(11):1787-94. PubMed ID: 15251170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A study on selective killing effect of Hsv-tk/GCV driven by human telomerase catalytic subunit promoter on human lung cancer cell A549].
    Tang XJ; Wang YP; Zhou QH; Che GW; Chen XH; Zhu DX
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Apr; 24(2):148-52. PubMed ID: 17407070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combine cancer gene therapy harnessing plasmids expressing human tumor necrosis factor alpha and Herpes simplex thymidine kinase suicide gene.
    Pastorakova A; Hlubinova K; Jakubikova J; Altaner C
    Neoplasma; 2006; 53(5):353-62. PubMed ID: 17013529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new targeting approach for breast cancer gene therapy using the human fatty acid synthase promoter.
    Yan C; Wen-Chao L; Hong-Yan Q; Rui Z; Wei-Lin J; Hua H
    Acta Oncol; 2007; 46(6):773-81. PubMed ID: 17653900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of the radio-inducible TK suicide gene controlled by Egr-1 promoter in pancreatic cancer cells: an in vitro experiment].
    Liu JL; Liu XL; Qian Q; Du Q; Guo SY; Li CJ; Miao Y
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1952-5. PubMed ID: 19062733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.